Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Long-Term Deferred Tax (2020 - 2025)

MDxHealth has reported Long-Term Deferred Tax over the past 5 years, most recently at $1.6 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, changed N/A, while the annual FY2025 figure was $1.6 million, N/A changed from the prior year.
  • Long-Term Deferred Tax was $1.6 million for Q4 2025 at MDxHealth, down from $10.8 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $11.0 million in Q4 2022 and bottomed at $1.6 million in Q4 2025.
  • The 4-year median for Long-Term Deferred Tax is $9.0 million (2021), against an average of $7.7 million.
  • Year-over-year, Long-Term Deferred Tax soared 51.85% in 2022 and then decreased 2.14% in 2023.
  • Over 4 years, Long-Term Deferred Tax stood at $7.3 million in 2021, then soared by 51.85% to $11.0 million in 2022, then decreased by 2.14% to $10.8 million in 2023, then plummeted by 85.15% to $1.6 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $1.6 million (Q4 2025), $10.8 million (Q4 2023), and $11.0 million (Q4 2022) per Business Quant data.